U.S. flag

An official website of the United States government

NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys) AND Abdominal obesity-metabolic syndrome 3

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 15, 2014
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000119261.3

Allele description [Variation Report for NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)]

NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)

Gene:
DYRK1B:dual specificity tyrosine phosphorylation regulated kinase 1B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)
HGVS:
  • NC_000019.10:g.39830443G>A
  • NG_034145.1:g.8791C>T
  • NM_004714.3:c.304C>TMANE SELECT
  • NM_006483.3:c.304C>T
  • NM_006484.3:c.304C>T
  • NP_004705.1:p.Arg102Cys
  • NP_006474.1:p.Arg102Cys
  • NP_006475.1:p.Arg102Cys
  • NC_000019.9:g.40321083G>A
  • NM_004714.1:c.304C>T
  • Q9Y463:p.Arg102Cys
Protein change:
R102C; ARG102CYS
Links:
UniProtKB: Q9Y463#VAR_071774; OMIM: 604556.0001; dbSNP: rs367643250
NCBI 1000 Genomes Browser:
rs367643250
Molecular consequence:
  • NM_004714.3:c.304C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006483.3:c.304C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006484.3:c.304C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Abdominal obesity-metabolic syndrome 3 (AOMS3)
Synonyms:
CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE
Identifiers:
MONDO: MONDO:0014352; MedGen: C4014361; OMIM: 615812

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000154696OMIM
no assertion criteria provided
Pathogenic
(May 15, 2014)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A form of the metabolic syndrome associated with mutations in DYRK1B.

Keramati AR, Fathzadeh M, Go GW, Singh R, Choi M, Faramarzi S, Mane S, Kasaei M, Sarajzadeh-Fard K, Hwa J, Kidd KK, Babaee Bigi MA, Malekzadeh R, Hosseinian A, Babaei M, Lifton RP, Mani A.

N Engl J Med. 2014 May 15;370(20):1909-1919. doi: 10.1056/NEJMoa1301824.

PubMed [citation]
PMID:
24827035
PMCID:
PMC4069260

Details of each submission

From OMIM, SCV000154696.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 3 multigenerational Iranian families segregating autosomal dominant abdominal obesity-metabolic syndrome (AOMS3; 615812) and early-onset coronary artery disease, Keramati et al. (2014) identified a heterozygous c.304C-T transition in the DYRK1B gene, resulting in an arg102-to-cys (R102C) substitution at a highly conserved residue in the kinase-like domain. The mutation, which segregated completely with disease in all 3 families, was not found in 2,000 ethnically matched Iranian controls or 3,600 Caucasian controls from the United States, or in samples from 2,500 individuals in the Allele Frequency Database, 5,000 exomes from the Yale Center for Genome Analysis database, or 5,400 exomes in the NHLBI ESP5400 database. Functional analysis of transfected 3T3-L1 cells showed that accumulation of intracellular lipid was significantly greater with R102C than wildtype DYRK1B, and cells expressing the R102C variant were able to transform into mature adipocytes without requiring adipogenic medium. Expression levels of CEBPA (116897), PPARG (601487) isoforms 1 and 2, and PGC1A (PPARGC1A; 604517) were higher, and those of GLI1 (165220) and p27(KIP1) (CDKN1B; 600778) were lower in cells transfected with the R102C mutant compared to wildtype. In addition, WNT (see 164820) signaling activity was lower in mutant cells compared to wildtype.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024